Colgate-Palmolive (NYSE:CL – Get Rating) had its price target decreased by Wells Fargo & Company from $80.00 to $76.00 in a report issued on Monday, Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.
CL has been the subject of several other research reports. JPMorgan Chase & Co. lifted their price target on shares of Colgate-Palmolive from $81.00 to $86.00 and gave the company an overweight rating in a research report on Friday, January 13th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Colgate-Palmolive from $87.00 to $84.00 in a report on Monday. Barclays boosted their price target on shares of Colgate-Palmolive from $72.00 to $76.00 and gave the stock an equal weight rating in a report on Tuesday, November 1st. The Goldman Sachs Group cut their price target on shares of Colgate-Palmolive from $91.00 to $81.00 and set a buy rating on the stock in a report on Monday, October 10th. Finally, Wolfe Research assumed coverage on shares of Colgate-Palmolive in a report on Monday, November 21st. They issued a market perform rating on the stock. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and a consensus target price of $81.90.
Get Colgate-Palmolive alerts:Colgate-Palmolive Stock Down 1.7 %
NYSE:CL opened at $73.73 on Monday. The firm's 50 day simple moving average is $77.48 and its 200 day simple moving average is $76.55. The company has a debt-to-equity ratio of 7.81, a current ratio of 0.40 and a quick ratio of 0.24. Colgate-Palmolive has a one year low of $67.84 and a one year high of $83.81. The company has a market cap of $61.58 billion, a PE ratio of 34.77, a P/E/G ratio of 3.87 and a beta of 0.50.
Colgate-Palmolive (NYSE:CL – Get Rating) last posted its earnings results on Friday, January 27th. The company reported $0.77 EPS for the quarter, hitting the consensus estimate of $0.77. Colgate-Palmolive had a net margin of 9.93% and a return on equity of 317.08%. The business had revenue of $4.63 billion for the quarter, compared to the consensus estimate of $4.58 billion. During the same period last year, the company earned $0.79 EPS. The firm's revenue was up 5.1% compared to the same quarter last year. On average, research analysts anticipate that Colgate-Palmolive will post 3.1 earnings per share for the current year.Colgate-Palmolive Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, February 14th. Shareholders of record on Monday, January 23rd will be paid a $0.47 dividend. This represents a $1.88 annualized dividend and a yield of 2.55%. The ex-dividend date is Friday, January 20th. Colgate-Palmolive's dividend payout ratio is currently 88.26%.
Institutional Trading of Colgate-Palmolive
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of Colgate-Palmolive by 1.1% during the third quarter. Vanguard Group Inc. now owns 78,638,269 shares of the company's stock valued at $5,524,338,000 after purchasing an additional 882,517 shares during the period. Third Point LLC boosted its stake in shares of Colgate-Palmolive by 481.9% during the third quarter. Third Point LLC now owns 11,550,000 shares of the company's stock valued at $811,388,000 after purchasing an additional 9,565,000 shares during the period. Northern Trust Corp boosted its stake in shares of Colgate-Palmolive by 0.5% during the first quarter. Northern Trust Corp now owns 10,470,409 shares of the company's stock valued at $793,971,000 after purchasing an additional 50,040 shares during the period. Deutsche Bank AG boosted its stake in shares of Colgate-Palmolive by 33.3% during the second quarter. Deutsche Bank AG now owns 10,441,903 shares of the company's stock valued at $836,815,000 after purchasing an additional 2,610,321 shares during the period. Finally, Legal & General Group Plc boosted its stake in shares of Colgate-Palmolive by 4.1% during the second quarter. Legal & General Group Plc now owns 7,709,706 shares of the company's stock valued at $617,858,000 after purchasing an additional 301,219 shares during the period. Hedge funds and other institutional investors own 77.63% of the company's stock.
About Colgate-Palmolive
(Get Rating)
Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.
Further Reading
- Get a free copy of the StockNews.com research report on Colgate-Palmolive (CL)
- Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
- Mullen Automotive Stock Gains Momentum On Positive News
- Harley-Davidson Inc. Stock, Is It Time To Buy?
- The Bottom Is In For Meta Platforms, Volatility Is Not Over
- Analyzing Alaska Air's Recent Earnings
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.